In summary, our results showed that GNAS KO not only sensitized DLBCL cells to HDAC3 inhibition through cell-intrinsic IFN responses but also potentiated CD8+ T cell-induced cytotoxicity with HDAC3 inhibition. The gene discussed is HDAC3; the disease is diffuse large B-cell lymphoma.